Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass
Cardiopulmonary bypass (CPB) with extracorporeal circulation produces changes in the immune system accompanied by an increase in proinflammatory cytokines and a decrease in anti-inflammatory cytokines. We hypothesize that dexmedetomidine (DEX) as an anesthetic adjuvant modulates the inflammatory res...
Main Authors: | N.M.H. Bulow, E. Colpo, R.P. Pereira, E.F.M. Correa, E.P. Waczuk, M.F. Duarte, J.B.T. Rocha |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2016-01-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2016000400702&lng=en&tlng=en |
Similar Items
-
Effects of dexmedetomidine on stress hormones in patients undergoing cardiac valve replacement: a randomized controlled trial
by: Hanhua Wu, et al.
Published: (2020-06-01) -
Effects of dexmedetomidine on the expression of inflammatory factors in children with congenital heart disease undergoing intraoperative cardiopulmonary bypass: a randomized controlled trial
by: Yongsheng Qiu, et al.
Published: (2020-03-01) -
Hemodynamic stability and analgesic effects of intravenous dexmedetomidine premedication in adult patients undergoing coronary artery bypass graft surgery
by: Zahra Faritus, et al.
Published: (2018-01-01) -
Dexmedetomidine reduces the neuronal apoptosis related to cardiopulmonary bypass by inhibiting activation of the JAK2–STAT3 pathway
by: Chen Y, et al.
Published: (2017-09-01) -
Ultrafiltration Technology and Its Application in Cardiopulmonary Bypass
by: Zhang Kun, et al.
Published: (2017-01-01)